Skip to main content
SpringerLink
Log in

Outcomes of Kidney and Pancreas Transplantation

  • Chapter
  • First Online:
Book cover Kidney and Pancreas Transplantation

Part of the book series: Current Clinical Urology ((CCU))

  • 1740 Accesses

Abstract

The transplant physician and surgeon need to have a sound understanding of transplant outcomes. The authors review various factors that impact survival of kidney and pancreas transplantation. Also discussed are the implications of outcomes data on patient and regimen selection. The basic premises of survival analysis and relevant terminology are presented in the context of a framework for clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Scientific Registry of Renal Transplant Recipients: 2008 Annual Report. 2008, Available from: http://www.ustransplant.org

  2. United States Renal Data System: 2008 Annual Report. 2008, Available from: www.usrds.org

  3. United Network for Organ Sharing: 2008 Annual Report. 2008.

    Google Scholar 

  4. Available from

    Google Scholar 

  5. Kaplan B, Schold J, Meier-Kriesche HU. Overview of large database analysis in renal transplantation. Am J Transplant 2003;3(9):1052–1056.

    Article  PubMed  Google Scholar 

  6. Opelz G, Mickey MR, Terasaki PI. Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc 1977;9(1):27–30.

    CAS  Google Scholar 

  7. Halloran PF, Gourishankar S, Vongwiwatan, A, Weir MR. Approaching the renal transplant patient with deteriorating function: Progressive loss of function is not inevitable. In: Weir MR (ed.). Medical Management of Kidney Transplantation. Philadelphia: Lippincott, Williams & Wilkins, 2005: 389–402.

    Google Scholar 

  8. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8(4):753–760.

    Article  PubMed  CAS  Google Scholar 

  9. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. NEJM 1999;341(23):1725–1730.

    Article  PubMed  CAS  Google Scholar 

  10. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003;75(8):1291–1295.

    Article  PubMed  Google Scholar 

  11. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 2004;4(10):1662–1668.

    Article  PubMed  Google Scholar 

  12. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU. The broad spectrum of quality in deceased donor kidneys. Am J Transplant 2005;5(4 Pt 1):757–765.

    Article  PubMed  Google Scholar 

  13. McCullough KP, Keith DS, Meyer KH, Stock PG, Brayman KL, Leichtman AB. Kidney and pancreas transplantation in the United States, 1998–2007: access for patients with diabetes and end-stage renal disease. Am J Transplant 2009;9(4 Pt 2):894–906.

    Article  PubMed  CAS  Google Scholar 

  14. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. NEJM 2000;342(9):605–612.

    Article  PubMed  CAS  Google Scholar 

  15. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004;4(8):1289–1295.

    Article  PubMed  Google Scholar 

  16. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4(3):378–383.

    Article  PubMed  Google Scholar 

  17. Meier-Kriesche HU, Ojo AO, Hanson JA, Cibrik DM, Punch JD, Leichtman AB, et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000;70(7):1098–1100.

    Article  PubMed  CAS  Google Scholar 

  18. Kaplan B, Srinivas TR, Meier-Kriesche HU. Factors associated with long-term renal allograft survival. Ther Drug Monit 2002;24(1):36–39.

    Article  PubMed  Google Scholar 

  19. Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. NEJM 2003;349(24):2326–2333.

    Article  PubMed  CAS  Google Scholar 

  20. Srinivas TR, Meier-Kriesche HU. Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol 2008;3(Suppl 2):S101–116.

    Article  PubMed  CAS  Google Scholar 

  21. El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009;9(3):527–535.

    Article  PubMed  CAS  Google Scholar 

  22. Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transplant Int 2009;22(7):770.

    Article  Google Scholar 

  23. Halloran PF, Hunsicker LG. Delayed graft function: state of the art, November 10–11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001;1(2):115–120.

    Google Scholar 

  24. Howard RJ, Pfaff WW, Brunson ME, Scornik JC, Ramos EL, Peterson JC, et al. Increased incidence of rejection in patients with delayed graft function. Clin Transplant 1994;8(6):527–531.

    CAS  Google Scholar 

  25. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998;66(12):1697–1701.

    Article  PubMed  CAS  Google Scholar 

  26. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997;63(7):968–974.

    Article  PubMed  CAS  Google Scholar 

  27. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000;58(2):859–866.

    Article  PubMed  CAS  Google Scholar 

  28. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant 2005;5(7):1681–1688.

    Article  PubMed  Google Scholar 

  29. Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. NEJM 2009;360(1):7–19.

    Article  PubMed  CAS  Google Scholar 

  30. Held PJ, Kahan BD, Hunsicker LG, Liska D, Wolfe RA, Port FK, et al. The impact of HLA mismatches on the survival of first cadaveric kidney transplants. NEJM 1994;331(12):765–770.

    Article  PubMed  CAS  Google Scholar 

  31. Vereerstraeten P, Abramowicz D, De Pauw L, Kinnaert P. Experience with the Wujciak-Opelz allocation system in a single center: an increase in HLA-DR mismatching and in early occurring acute rejection episodes. Transplant Int 1998;11(5):378–381.

    Article  PubMed  CAS  Google Scholar 

  32. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003;3(6):665–673.

    Article  PubMed  Google Scholar 

  33. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. NEJM 1995;333(6):333–336.

    Article  PubMed  CAS  Google Scholar 

  34. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000;58(3):1311–1317.

    Article  PubMed  CAS  Google Scholar 

  35. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. NEJM 2001;344(10):726–731.

    Article  PubMed  CAS  Google Scholar 

  36. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002;74(10):1377–1381.

    Article  PubMed  Google Scholar 

  37. Augustine JJ, Poggio ED, Clemente M, Aeder MI, Bodziak KA, Schulak JA, et al. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. J Am Soc Nephrol 2007;18(5):1602–1606.

    Article  PubMed  Google Scholar 

  38. Schold JD, Srinivas TR, Howard RJ, Jamieson IR, Meier-Kriesche HU. The association of candidate mortality rates with kidney transplant outcomes and center performance evaluations. Transplantation 2008;85(1):1–6.

    Article  PubMed  Google Scholar 

  39. Schold JD, Harman JS, Chumbler NR, Duncan RP, Meier-Kriesche HU. The pivotal impact of center characteristics on survival of candidates listed for deceased donor kidney transplantation. Med Care 2009;47(2):146–153.

    Article  PubMed  Google Scholar 

  40. Takemoto S, Terasaki PI. Donor age and recipient age. Clin Transplant 1988:345–356.

    Google Scholar 

  41. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999;10(1):167–181.

    PubMed  CAS  Google Scholar 

  42. Dharnidharka VR, Stevens G, Howard RJ. En-bloc kidney transplantation in the United States: an analysis of united network of organ sharing (UNOS) data from 1987 to 2003. Am J Transplant 2005;5(6):1513–1517.

    Article  PubMed  Google Scholar 

  43. Salahudeen AK, Haider N, May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004;65(2):713–718.

    Article  PubMed  Google Scholar 

  44. Hughson M, Farris AB, 3rd, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 2003;63(6):2113–2122.

    Article  PubMed  Google Scholar 

  45. Zeier M, Dohler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol 2002;13(10):2570–2576.

    Article  PubMed  Google Scholar 

  46. Neugarten J, Srinivas T, Tellis V, Silbiger S, Greenstein S. The effect of donor gender on renal allograft survival. J Am Soc Nephrol 1996;7(2):318–324.

    PubMed  CAS  Google Scholar 

  47. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992;3(2):162–169.

    PubMed  CAS  Google Scholar 

  48. Poggio ED, Hila S, Stephany B, Fatica R, Krishnamurthi V, del Bosque C, et al. Donor kidney volume and outcomes following live donor kidney transplantation. Am J Transplant 2006;6(3):616–624.

    Article  PubMed  CAS  Google Scholar 

  49. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant 2003;3(Suppl 4):114–125.

    Article  PubMed  Google Scholar 

  50. Ojo AO, Hanson JA, Meier-Kriesche H, Okechukwu CN, Wolfe RA, Leichtman AB, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001;12(3):589–597.

    PubMed  CAS  Google Scholar 

  51. Merion RM, Ashby VB, Wolfe RA, Distant DA, Hulbert-Shearon TE, Metzger RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005;294(21):2726–2733.

    Article  PubMed  CAS  Google Scholar 

  52. Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose hearts have stopped beating. NEJM 1998;338(4):221–225.

    Article  PubMed  CAS  Google Scholar 

  53. Cooper JT, Chin LT, Krieger NR, Fernandez LA, Foley DP, Becker YT, et al. Donation after cardiac death: the University of Wisconsin experience with renal transplantation. Am J Transplant 2004;4(9):1490–1494.

    Article  PubMed  Google Scholar 

  54. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol 2009;4(7):1239–1245.

    Article  PubMed  Google Scholar 

  55. Meier-Kriesche HU, Ojo AO, Cibrik DM, Hanson JA, Leichtman AB, Magee JC, et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 2000;70(2):306–310.

    Article  PubMed  CAS  Google Scholar 

  56. Meier-Kriesche HU, Cibrik DM, Ojo AO, Hanson JA, Magee JC, Rudich SM, et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc 2002;50(1):14–17.

    Article  PubMed  Google Scholar 

  57. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int 2001;59(4):1539–1543.

    Article  PubMed  CAS  Google Scholar 

  58. Meier-Kriesche HU, Ojo AO, Leichtman AB, Punch JD, Hanson JA, Cibrik DM, et al. Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients. J Am Soc Nephrol 2000;11(12):2366–2370.

    PubMed  CAS  Google Scholar 

  59. Neylan JF. Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group. Transplant Proc 1998;30(4):1355–1358.

    Article  CAS  Google Scholar 

  60. Light JA, Barhyte DY, Lahman L. Kidney transplants in African Americans and non-African Americans: equivalent outcomes with living but not deceased donors. Transplant Proc 2005;37(2):699–700.

    Article  CAS  Google Scholar 

  61. Kayler LK, Rasmussen CS, Dykstra DM, Ojo AO, Port FK, Wolfe RA, et al. Gender imbalance and outcomes in living donor renal transplantation in the United States. Am J Transplant 2003;3(4):452–458.

    Article  PubMed  Google Scholar 

  62. Meier-Kriesche HU, Ojo AO, Leavey SF, Hanson JA, Leichtman AB, Magee JC, et al. Gender differences in the risk for chronic renal allograft failure. Transplantation 2001;71(3):429–432.

    Article  PubMed  CAS  Google Scholar 

  63. Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. NEJM 2008;359(3):242–251.

    Article  PubMed  CAS  Google Scholar 

  64. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005;5(6):1452–1461.

    Article  PubMed  CAS  Google Scholar 

  65. Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, et al. Effects of hepatitis C infection and renal transplantation on survival in ­end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998;53(5):1374–1381.

    Article  PubMed  CAS  Google Scholar 

  66. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation 2001;72(2):241–244.

    Article  PubMed  CAS  Google Scholar 

  67. Srinivas TR, Kaplan B, Schold JD, Meier-Kriesche HU. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplan­tation 2005;80(2 Suppl):S211–220.

    Article  PubMed  CAS  Google Scholar 

  68. Meier-Kriesche H, Ojo AO, Arndorfer JA, Magee JC, Cibrik DM, Leichtman AB, et al. Mycophenolate mofetil decreases the risk for chronic renal allograft failure. Transplant Proc 2001;33(1–2):1005–1006.

    Article  CAS  Google Scholar 

  69. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman AB, Cibrik D, Magee JC, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000;69(11):2405–2409.

    Article  PubMed  CAS  Google Scholar 

  70. Meier-Kriesche HU, Steffen BJ, Hochberg AM, Gordon RD, Liebman MN, Morris, JA, et al. Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection. Am J Transplant 2003;3(1):68–73.

    Article  PubMed  CAS  Google Scholar 

  71. Meier-Kriesche HU, Steffen BJ, Hochberg AM, Gordon RD, Liebman MN, Morris JA, et al. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation 2003;75(8):1341–1346.

    Article  PubMed  CAS  Google Scholar 

  72. Meier-Kriesche HU, Li S, Gruessner RW, Fung JJ, Bustami RT, Barr ML, et al. Immunosuppression: evolution in practice and trends, 1994–2004. Am J Transplant 2006;6(5 Pt 2):1111–1131.

    Article  PubMed  CAS  Google Scholar 

  73. Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation 2003;75(8):1213–1220.

    Article  PubMed  CAS  Google Scholar 

  74. MacDonald AS. Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation. Transplant Proc 2003;35(3 Suppl):201S–208S.

    Article  CAS  Google Scholar 

  75. Formica RN, Jr., Lorber KM, Friedman AL, Bia MJ, Lakkis F, Smith JD, et al. Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation. Transplant Proc 2003;35(3 Suppl):95S–98S.

    Article  CAS  Google Scholar 

  76. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005;5(9):2273–2280.

    Article  PubMed  CAS  Google Scholar 

  77. Meier-Kriesche HU, Steffen BJ, Chu AH, Loveland JJ, Gordon RD, Morris JA, et al. Sirolimus with Neoral versus mycophenolate mofetil with Neoral is associated with decreased renal allograft survival. Am J Transplant 2004;4(12):2058–2066.

    Article  PubMed  CAS  Google Scholar 

  78. Mendez R, Gonwa T, Yang HC, Weinstein S, Jensik S, Steinberg S. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation 2005;80(3):303–309.

    Article  PubMed  CAS  Google Scholar 

  79. Flechner SM, Goldfarb D, Modlin C, Feng J, Krishnamurthi V, Mastroianni B, et al. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002;74(8):1070–1076.

    Article  PubMed  CAS  Google Scholar 

  80. Larson TS, Dean PG, Stegall MD, Griffin MD, Textor SC, Schwab TR, et al. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006;6(3):514–522.

    Article  PubMed  CAS  Google Scholar 

  81. Srinivas TR, Schold JD, Guerra G, Eagan A, Bucci CM, Meier-Kriesche HU. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant 2007;7(3):586–594.

    Article  PubMed  CAS  Google Scholar 

  82. Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. NEJM 2007;357(25):2562–2575.

    Article  PubMed  CAS  Google Scholar 

  83. Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, et al. Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant 2005;5(10):2473–2478.

    Article  PubMed  Google Scholar 

  84. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008;248(4):564–577.

    PubMed  Google Scholar 

  85. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A. Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant 2007;7(8):1948–1953.

    Article  PubMed  CAS  Google Scholar 

  86. Luan FL, Steffick DE, Gadegbeku C, Norman SP, Wolfe R, Ojo AO. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant 2009;9(1):160–168.

    Article  PubMed  CAS  Google Scholar 

  87. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. NEJM 2006;355(19):1967–1977.

    Article  PubMed  CAS  Google Scholar 

  88. Meier-Kriesche HU, Arndorfer JA, Kaplan B. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol 2002;13(3):769–772.

    PubMed  Google Scholar 

  89. Vlaminck H, Maes B, Evers G, Verbeke G, Lerut E, Van Damme B, et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004;4(9):1509–1513.

    Article  PubMed  Google Scholar 

  90. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B. The effect of body mass index on long-term renal allograft survival. Transplantation 1999;68(9):1294–1297.

    Article  PubMed  CAS  Google Scholar 

  91. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002;73(1):70–74.

    Article  PubMed  Google Scholar 

  92. Glanton CW, Kao TC, Cruess D, Agodoa LY, Abbott KC. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003;63(2):647–653.

    Article  PubMed  Google Scholar 

  93. Schold JD, Srinivas TR, Guerra G, Reed AI, Johnson RJ, Weiner ID, et al. A “weight-listing” paradox for candidates of renal transplantation? Am J Transplant 2007;7(3):550–559.

    Article  PubMed  CAS  Google Scholar 

  94. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998;53(1):217–222.

    Article  PubMed  CAS  Google Scholar 

  95. Shihab FS, Bennett WM, Tanner AM, Andoh TF. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 1997;52(3):660–673.

    Article  PubMed  CAS  Google Scholar 

  96. Lin J, Valeri AM, Markowitz GS, D’Agati VD, Cohen DJ, Radhakrishnan J. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 2002;73(5):783–788.

    Article  PubMed  CAS  Google Scholar 

  97. Knoll GA, Cantarovitch M, Cole E, Gill J, Gourishankar S, Holland D, et al. The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation – study design. Nephrol Dial Transplant 2008;23(1):354–358.

    Article  PubMed  CAS  Google Scholar 

  98. Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003;361(9374):2024–2031.

    Article  PubMed  CAS  Google Scholar 

  99. Wiesbauer F, Heinze G, Mitterbauer C, Harnoncourt F, Horl WH, Oberbauer R. Statin use is associated with prolonged survival of renal transplant recipients­. J Am Soc Nephrol 2008;19(11):2211–2218.

    Article  PubMed  Google Scholar 

  100. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from ­recurrent glomerulonephritis. NEJM 2002;347(2):103–109.

    Article  PubMed  Google Scholar 

  101. Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, et al. Proteinuria after kidney ­transplantation, relationship to allograft histology and survival. Am J Transplant 2007;7(12):2748–2756.

    Article  PubMed  CAS  Google Scholar 

  102. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and ­preserved kidney function. JAMA 2003;290(21):2817–2823.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology and Hypertension, Glickman Urologic and Kidney Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Titte R. Srinivas

Authors
  1. Titte R. Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Herwig-Ulf Meier-Kriesche
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jesse D. Schold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Titte R. Srinivas .

Editor information

Editors and Affiliations

  1. Glickman Urological & Kidney Institute, Children's Hospital of Cleveland Clinic, Euclid Ave. 9500, Cleveland, 44195, Ohio, USA

    T. R. Srinivas

  2. Glickman Urological & Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue 9500, Cleveland, 44195, Ohio, USA

    Daniel A. Shoskes

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Srinivas, T.R., Meier-Kriesche, HU., Schold, J.D. (2011). Outcomes of Kidney and Pancreas Transplantation. In: Srinivas, T., Shoskes, D. (eds) Kidney and Pancreas Transplantation. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-642-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-642-9_7

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-641-2

  • Online ISBN: 978-1-60761-642-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation